Brief: Cereno Scientific Initiates Collaboration With Cro Partner Oct To Conduct A Phase Ii Study
26/06/2018 07:48
Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC INITIATES COLLABORATION WITH CRO PARTNER
OCT
TO CONDUCT A PHASE II STUDY
* CONDUCT A PHASE II STUDY TO INVESTIGATE ANTITHROMBOTIC
EFFECTS
OF CERENOS CANDIDATE DRUG CS1.
Source text for Eikon: ID:nWkr5br2V0
Further company coverage: CRNOSb.TE
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global